Literature DB >> 11714862

Measurement of parameters of cholic acid kinetics in plasma using a microscale stable isotope dilution technique: application to rodents and humans.

C V Hulzebos1, L Renfurm, R H Bandsma, H J Verkade, T Boer, R Boverhof, H Tanaka, I Mierau, P J Sauer, F Kuipers, F Stellaard.   

Abstract

A stable isotope dilution method is described that allows measurement of cholic acid (CA) kinetics, that is, pool size, fractional turnover rate (FTR), and synthesis rate in mice, rats, and humans. Decay of administered [2,2,4,4-2H4]CA enrichment was measured in time in 50-microl plasma samples by gas-liquid chromatography/electron capture negative chemical ionization-mass spectrometry, applying the pentafluorobenzyl-trimethylsilyl derivative. The kinetic data expressed species-dependent differences. The CA pool sizes were 16.8 +/- 2.1, 10.6 +/- 1.2, and 2.4 +/- 0.7 micromol/100 g body weight for mice, rats, and humans, respectively. The FTR values were 0.44 +/- 0.03, 0.88 +/- 0.10, and 0.46 +/- 0.14 per day for mice, rats, and humans. The corresponding synthesis rates were 7.3 +/- 1.6, 9.3 +/- 0.1, and 1.0 +/- 0.2 micromol/100 g body weight per day. The human data agreed well with literature data obtained by conventional isotope dilution techniques. For rats and mice these are the first reported isotope dilution data. The method was validated by confirmation of isotopic equilibrium between biliary CA and plasma CA in the rat. Its applicability was demonstrated by the observation of increased CA FTR and CA synthesis rate in rats fed cholestyramine, which is known to increase fecal bile acid excretion. The presented stable isotope dilution method enables the determination of CA kinetic parameters in small plasma samples. The method can be applied in unanesthetized rodents with an intact enterohepatic circulation and may also be valuable when studying the development of human neonatal bile acid kinetics.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11714862

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  15 in total

1.  Intestinal FXR-mediated FGF15 production contributes to diurnal control of hepatic bile acid synthesis in mice.

Authors:  Johanna H M Stroeve; Gemma Brufau; Frans Stellaard; Frank J Gonzalez; Bart Staels; Folkert Kuipers
Journal:  Lab Invest       Date:  2010-06-07       Impact factor: 5.662

2.  Farnesoid X receptor activation increases cholesteryl ester transfer protein expression in humans and transgenic mice.

Authors:  Thomas Gautier; Willeke de Haan; Jacques Grober; Dan Ye; Matthias J Bahr; Thierry Claudel; Niels Nijstad; Theo J C Van Berkel; Louis M Havekes; Michael P Manns; Stefan M Willems; Pancras C W Hogendoorn; Laurent Lagrost; Folkert Kuipers; Miranda Van Eck; Patrick C N Rensen; Uwe J F Tietge
Journal:  J Lipid Res       Date:  2013-04-25       Impact factor: 5.922

3.  The hepatic WASH complex is required for efficient plasma LDL and HDL cholesterol clearance.

Authors:  Melinde Wijers; Paolo Zanoni; Nalan Liv; Dyonne Y Vos; Michelle Y Jäckstein; Marieke Smit; Sanne Wilbrink; Justina C Wolters; Ydwine T van der Veen; Nicolette Huijkman; Daphne Dekker; Niels Kloosterhuis; Theo H van Dijk; Daniel D Billadeau; Folkert Kuipers; Judith Klumperman; Arnold von Eckardstein; Jan Albert Kuivenhoven; Bart van de Sluis
Journal:  JCI Insight       Date:  2019-06-06

4.  Ezetimibe restores biliary cholesterol excretion in mice expressing Niemann-Pick C1-Like 1 only in liver.

Authors:  Weiqing Tang; Lin Jia; Yinyan Ma; Ping Xie; Jamie Haywood; Paul A Dawson; Jian Li; Liqing Yu
Journal:  Biochim Biophys Acta       Date:  2011-06-12

5.  Bile acid pool dynamics in progressive familial intrahepatic cholestasis with partial external bile diversion.

Authors:  Hilary S Jericho; Elizabeth Kaurs; Renze Boverhof; Alex Knisely; Benjamin L Shneider; Henkjan J Verkade; Peter F Whitington
Journal:  J Pediatr Gastroenterol Nutr       Date:  2015-03       Impact factor: 2.839

6.  Ursodeoxycholic acid accelerates bile acid enterohepatic circulation.

Authors:  Yunjing Zhang; Runqiu Jiang; Xiaojiao Zheng; Sha Lei; Fengjie Huang; Guoxiang Xie; Sandi Kwee; Herbert Yu; Christine Farrar; Beicheng Sun; Aihua Zhao; Wei Jia
Journal:  Br J Pharmacol       Date:  2019-07-06       Impact factor: 8.739

Review 7.  Role of the intestinal bile acid transporters in bile acid and drug disposition.

Authors:  Paul A Dawson
Journal:  Handb Exp Pharmacol       Date:  2011

Review 8.  Bile acid transporters.

Authors:  Paul A Dawson; Tian Lan; Anuradha Rao
Journal:  J Lipid Res       Date:  2009-06-04       Impact factor: 5.922

9.  Cholic acid mediates negative feedback regulation of bile acid synthesis in mice.

Authors:  Jia Li-Hawkins; Mats Gåfvels; Maria Olin; Erik G Lund; Ulla Andersson; Gertrud Schuster; Ingemar Björkhem; David W Russell; Gosta Eggertsen
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

10.  Hepatic overexpression of Abcb11 in mice promotes the conservation of bile acids within the enterohepatic circulation.

Authors:  Anne S Henkel; Karin E R Gooijert; Rick Havinga; Renze Boverhof; Richard M Green; Henkjan J Verkade
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-11-08       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.